Market Research Report
Global Markets for Infectious Disease Treatments
|Published by||BCC Research||Product code||117624|
|Published||Content info||315 Pages
|Global Markets for Infectious Disease Treatments|
|Published: March 1, 2018||Content info: 315 Pages||
The global market for infectious disease treatments totaled $64.8 billion in 2017. The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022.
The report focuses on newer drugs and innovations in chemical compounds, vaccines and biologicals and diagnostic kits, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control approaches, strategies and products; drugs used for symptomatic treatment and not for the elimination of the virus from the host; and details on manufacturers and suppliers of non-branded generics.
BCC Research has categorized the markets based on regions defined by the WHO since it is the primary organization mapping disease prevalence, assisting with access to medicine and enabling partnerships in a large number of infectious diseases. Regions include Africa, Americas, South-East Asia, Europe, Eastern Mediterranean and Western Pacific. These cover all the WHO participating countries, which are described in detail in the subsequent section.
Ms. Joshi has a master's degree in biotechnology from the Indian Institute of Technology (I.I.T), Mumbai, and a diploma in management consulting from the Consultancy Development Centre, DSIR, Ministry of Science and Technology, India. She has eight years of research experience in competitive intelligence, technology strategy and market analysis in the pharmaceuticals, biotechnology and agrochemical industries.